Cognizant, Microsoft collaborate to bring cloud-based solutions to the healthcare market

Microsoft Cloud for Healthcare and Cognizant’s TriZetto healthcare products aim to enhance transparency for consumers and increase interoperability for providers and payers

Tillotts Pharma announces the launch of Octasa 1600 mg Tablets in Canada

The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.

Bridgewest Group launches new sterile injectable CDMO NovaCina

CBC Group appoints Abbas Hussain as Operating Partner

Abbas will closely partner with CBC's business teams to identify, assess, and pursue investment opportunities and strategic acquisitions

EIP Pharma and Diffusion Pharmaceuticals inks agreement to create CNS-focused company

EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging

ProBioGen delivers strong 2022 performance

ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.

IIT Kanpur and University at Buffalo to enrich research in Biomedicine & Bioengineering

The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering

OPPI launches ‘Bharat Ke Liye’ to reinforce commitment to improve health outcomes

This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India

CTSI appoints Harish Trivedi as CEO, South Asia

Janssen announces novel dengue antiviral demonstrates efficacy in pre-clinical data

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans